Investing.com - Financial Markets Worldwide
Get 40% Off
Get 40% Off
These stocks are up over 10% post earnings. Did you spot the buying opportunity? Our AI did.Read how

NetraMark Holdings Inc (AIAI)

CBOE Canada
Symbol
Exchange
Currency
AIAICBOE CanadaCAD
AIAICSECAD
Currency in CAD
Disclaimer
0.34
0.00(0.00%)
Closed

AIAI Comments

NetraAI (full subsidiary of MEND) is being leveraged to lead the discovery phase of the research process in a joint-effort between Cyclica and Nurosene to accelerate novel drug discovery for neurodegenerative diseases. Tapping into a ~US$40B market.
Nurosene Health recently announced a partnership with Cyclica, leveraging their acquisition with NetraMark. NetraAI will be used to lead the discovery phase of the research process in a joint-effort plan accelerating drug discovery for neurodegenerative diseases - this market is valued at US$40B. This is significant news and follows $MNNDF’s breakout week.
2021 was a huge year for Nurosene, the mHealth company tapping into the massive $300B+ market and backed by a AAA roster of major celebrity endorsers. In October ‘21, $MEND closed the acquisition of the AI-driven pharmatech company Netramark for C$15M. Solid opportunity to learn more about their promising 2022 pipeline at the upcoming H.C. Wainwright Bioconnect Virtual Investor conference on January 10-13, 2022 - search the event on google for free registration.
What’s your point of entry? Q4 was huge for Nurosene, hitting all-time highs in November with a promise of much more with mHealth opportunities tapping into the massive $300B+ market. Definitely one to keep your eye on going into 2022, this blog has solid analysis from a portfolio manager with key insights into Nurosene’s 4-pronged approach generating revenues. Article titled 'Keep your eye on Nurosene Health, this portfolio manager says' on Cantechletter '
What's your point of entry? Tons of 'very bullish' ratings being called on the fresh-to-scene mHealth app, Nurosene. With a significant roster of celebrity endorsers and plenty media coverage, this shouldn't be a sleeper for long. They've hit all-time highs this week showing no upper chart resistance and are riding the mHealth rise tapping into the massive $300B+ market to grow in.
Good to hear that Dr. Geraci is presenting at ISCTM's 18th Annual Scientific Meeting about the use of machine learning and AI in drug development. The last month has been great for $MEND. Nick Jonas’s investment and a new president of Netramark will help grow both the app and their AI business. Upwards momentum should push this above $2 soon.
$MEND has been on the up, the AI-driven wellness company has been making a splash with a bevvy of high-profile celebrity endorsers and investors. Including Nick Jonas and NFL and NHL players. $MEND.c CEO, Ranj Bath will be presenting at the 3rd Annual Health & Wellness conference today. You can still register online for free, just search Nurosene to Present at the Canaccord Genuity 3rd Annual Health & Wellness Virtual Conference
About 33% of people report feeling extreme stress, 77% experience stress that affects their physical health, 73% have stress that impacts their mental health, and 48% have trouble sleeping because of stress. Accessibility and affordability are why mobile health will become a $300B+ market soon, and $MEND.CN is ready to become a leader in the space.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.